electroCore to present at LD Micro Invitational XVI on May 18, 2026, highlighting bioelectronic medicine advances

electroCore, Inc., a bioelectronic medicine company, announced it will present at the LD Micro Invitational XVI Conference on May 18, 2026, in Los Angeles. Interim President and CFO Joshua Lev will deliver the presentation and hold one-on-one meetings. The company focuses on non-invasive bioelectronic technologies for health, including products like gammaCore® and Quell® for chronic pain, and wellness devices Truvaga™ and TAC-STIM™. This event offers electroCore a platform to showcase its innovations and engage with investors and industry stakeholders.